The treatment of osteoporosis. Antiresorptive therapy.
Antiresorptive pharmacologic interventions for the prevention and treatment of osteoporosis are discussed. These interventions include estrogen; calcitonin; biphosphonates; and selective estrogen receptor modulators and their use in postmenopausal osteoporosis, steroid-induced osteoporosis, and osteoporosis in men. The effects of antiresorptive therapy on bone mineral density, biomarkers of bone turnover, and fracture risk are discussed.
Miller
P D
PD
Department of Medicine, University of Colorado Health Sciences Center, Lakewood, USA.
D015519:Bone Density; D016723:Bone Remodeling; D001862:Bone Resorption / Q000517:prevention & control*; D001842:Bone and Bones / Q000293:injuries; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D014807:Vitamin D / Q000627:therapeutic use
D004164:Diphosphonates; D004967:Estrogens; D014807:Vitamin D; D002116:Calcitonin; D002118:Calcium